Genetic determinants of breast cancer immune phenotypes

IMPAKT conference highlights

Mutational landscapes in pregnant and non-pregnant breast cancer

Resistance to CDK4/6 inhibitors

Deciphering the connection of genetics, immune infiltration and prognosis

Genetic vs immune strategies in breast cancer

Transforming patient care through translational research

Mechanisms of resistance to CDK4/6 inhibitors in triple negative breast cancer

pSTAT3 in luminal breast cancer - results from BIG-2-98 trial

Increased long-term risk of breast cancer with high intra-tumour ER hetrogeneity

GTX-024 for androgen receptor positive breast cancer

Adaptive trial design on breast cancer